Concepedia
Statistics
Publications
13
Citations
1.4K
H-Index
12
Active since
2017
Affiliations
Peking University(Current)
Changzhi Medical College
Henan Cancer Hospital
Peking University Cancer Hospital
Changzhi Medical College Peace Hospital
Junyan Yu is an author at Peking University specializing in medicine, oncology, and pharmacology.
Publications per year
2017–2024
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Jin Lü, Yuxian Bai, Teng Mao et al. · JAMA · 2021 · 801 citations · Full text
Medicine, Oncology, Pharmacology +17
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
Shengxiang Ren, Jianhua Chen, Xingxiang Xu et al. · Journal of Thoracic Oncology · 2021 · 313 citations
Medicine, Oncology, Pharmacology +6
On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial
Tao Jiang, Jianhua Chen, Xingxiang Xu et al. · Molecular Cancer · 2022 · 54 citations · Full text
RUNX3 inhibits the proliferation and metastasis of gastric cancer through regulating miR-182/HOXA9
Junyan Yu, Xiangyang Tian, Jianlan Chang et al. · Biomedicine & Pharmacotherapy · 2017 · 40 citations
Medicine, Cancer Biology, Oncology +12
The RNA helicase DHX33 is required for cancer cell proliferation in human glioblastoma and confers resistance to PI3K/mTOR inhibition
Hongzhong Wang, Junyan Yu, Xingshun Wang et al. · Cellular Signalling · 2018 · 25 citations
Medicine, Molecular Biology, Oncology +17
1–5 of 13